Skip to main content
. 2018 May;59(5):733–739. doi: 10.2967/jnumed.117.204032

FIGURE 1.

FIGURE 1.

A 66-y-old man with biochemical recurrence of prostate cancer (PSA level, 29.3 ng/mL). Sagittal 18F-fluciclovine PET/CT (A), CT (B), and PET (C) found single suggestive focus of uptake in prostate resection bed. Patient underwent external-beam radiation of lesion, with corresponding PSA nadir (0.27 ng/mL)